Virtus · 2014-12-16 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$2.2M | — | — | $46.0M | 每日估算 |
| 2026-07-30 | -$443,575 | — | — | $46.4M | 每日估算 |
| 2026-07-29 | +$911,332 | — | — | $47.3M | 每日估算 |
| 2026-07-28 | -$5.6M | — | — | $47.2M | 每日估算 |
| 2026-07-27 | +$3.0M | — | — | $52.7M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
DGCXX DREYFUS GOVERNMENT CASH MANAGE | STIV | 852,188 | $852,188 | 2.28% |
ERAS ERASCA INC COM | EC | 76,668 | $816,514 | 2.19% |
ELVN ENLIVEN THERAPEUTICS INC COM | EC | 16,370 | $674,935 | 1.81% |
TNGX TANGO THERAPEUTICS INC COM |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$639,999 | — | — | $50.3M | 每日估算 |
| 2026-07-25 | +$639,999 | — | — | $50.3M | 每日估算 |
| 2026-04-30 | +$175,236 | $2.3M | $2.1M | $37.3M | SEC 月度 |
| 2026-03-31 | -$2.0M | $0 | $2.0M | — | SEC 月度 |
| 2026-02-28 | -$26,300 | $2.0M | $2.0M | — | SEC 月度 |
| EC |
| 29,518 |
| $638,179 |
| 1.71% |
ORKA ORUKA THERAPEUTICS INC COM | EC | 9,143 | $625,473 | 1.68% |
SYRE SPYRE THERAPEUTICS INC COM NEW | EC | 8,208 | $611,086 | 1.64% |
ALMS ALUMIS INC COM | EC | 24,020 | $593,054 | 1.59% |
DNTH DIANTHUS THERAPEUTICS INC COM | EC | 6,551 | $575,178 | 1.54% |
KOD KODIAK SCIENCES INC COM | EC | 11,591 | $503,977 | 1.35% |
RVMD REVOLUTION MEDICINES INC COM | EC | 3,496 | $503,844 | 1.35% |
CRVS CORVUS PHARMACEUTICALS INC COM | EC | 32,976 | $500,905 | 1.34% |
RZLT REZOLUTE INC COM NEW | EC | 153,338 | $490,682 | 1.31% |
DFTX DEFINIUM THERAPEUTICS INC COM SHS | EC | 21,993 | $481,207 | 1.29% |
CGON CG ONCOLOGY INC COM | EC | 6,741 | $449,894 | 1.21% |
JBIO JADE BIOSCIENCES INC COM NEW | EC | 18,425 | $449,570 | 1.20% |
INBX INHIBRX BIOSCIENCES INC COM | EC | 3,467 | $447,971 | 1.20% |
RLAY RELAY THERAPEUTICS INC COM | EC | 34,371 | $445,448 | 1.19% |
GHRS GH RESEARCH PLC ORDINARY SHARES | EC | 21,175 | $434,723 | 1.16% |
NKTR NEKTAR THERAPEUTICS COM NEW | EC | 5,045 | $429,027 | 1.15% |
TYRA TYRA BIOSCIENCES INC COM | EC | 12,196 | $423,811 | 1.14% |
VIR VIR BIOTECHNOLOGY INC COM | EC | 41,256 | $421,430 | 1.13% |
NTLA INTELLIA THERAPEUTICS INC COM | EC | 30,599 | $412,475 | 1.10% |
CNTA CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | EC | 10,411 | $410,402 | 1.10% |
ANAB ANAPTYSBIO INC COM | EC | 6,139 | $403,516 | 1.08% |
OMER OMEROS CORP COM | EC | 27,192 | $397,003 | 1.06% |
TECX TECTONIC THERAPEUTIC INC COM | EC | 13,966 | $390,629 | 1.05% |
ALLO ALLOGENE THERAPEUTICS INC COM | EC | 182,788 | $389,338 | 1.04% |
CMPS COMPASS PATHWAYS PLC SPONSORED ADS | EC | 40,950 | $371,007 | 0.99% |
EWTX EDGEWISE THERAPEUTICS INC COM | EC | 11,685 | $361,768 | 0.97% |
PVLA PALVELLA THERAPEUTICS INC COM | EC | 2,798 | $359,039 | 0.96% |
CAPR CAPRICOR THERAPEUTICS INC COM NEW | EC | 10,606 | $356,149 | 0.95% |
PCVX VAXCYTE INC COM | EC | 6,201 | $354,945 | 0.95% |
PHVS PHARVARIS NV COM | EC | 11,424 | $354,258 | 0.95% |
AVBP ARRIVENT BIOPHARMA INC COM | EC | 11,300 | $351,317 | 0.94% |
XENE XENON PHARMACEUTICALS INC COM | EC | 6,264 | $351,035 | 0.94% |
NGNE NEUROGENE INC COM | EC | 13,193 | $344,205 | 0.92% |
SMMT SUMMIT THERAPEUTICS INC COM | EC | 15,708 | $337,094 | 0.90% |
AMLX AMYLYX PHARMACEUTICALS INC COM | EC | 21,068 | $337,088 | 0.90% |
CLDX CELLDEX THERAPEUTICS INC COM NEW | EC | 10,032 | $329,852 | 0.88% |
PRAX PRAXIS PRECISION MEDICINES INC COM NEW | EC | 1,026 | $327,120 | 0.88% |
RCUS ARCUS BIOSCIENCES INC COM | EC | 12,819 | $326,885 | 0.88% |
ANNX ANNEXON INC COM | EC | 55,535 | $325,990 | 0.87% |
TERN TERNS PHARMACEUTICALS INC COM | EC | 6,132 | $324,567 | 0.87% |
LQDA LIQUIDIA CORP COM NEW | EC | 8,268 | $324,188 | 0.87% |
GLUE MONTE ROSA THERAPEUTICS INC COM | EC | 16,922 | $324,056 | 0.87% |
IMNM IMMUNOME INC COM | EC | 14,102 | $323,500 | 0.87% |
BCAX BICARA THERAPEUTICS INC COM | EC | 14,934 | $322,276 | 0.86% |
CELC CELCUITY INC COM | EC | 2,621 | $318,058 | 0.85% |
IRWD IRONWOOD PHARMACEUTICALS INC COM CL A | EC | 77,097 | $318,025 | 0.85% |
ABCL ABCELLERA BIOLOGICS INC COM | EC | 76,245 | $316,417 | 0.85% |
PGEN PRECIGEN INC COM | EC | 74,799 | $311,164 | 0.83% |
BLTE BELITE BIO INC SPONSORED ADS | EC | 1,952 | $310,680 | 0.83% |
BEAM BEAM THERAPEUTICS INC COM | EC | 10,087 | $305,939 | 0.82% |
MLTX MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | EC | 18,661 | $305,667 | 0.82% |
TSHA TAYSHA GENE THERAPIES INC COM SHS | EC | 47,669 | $304,605 | 0.82% |
CGEM CULLINAN THERAPEUTICS INC COM | EC | 23,153 | $302,147 | 0.81% |
IMTX IMMATICS NV SHS | EC | 27,490 | $302,115 | 0.81% |
RAPP RAPPORT THERAPEUTICS INC COM | EC | 9,118 | $302,079 | 0.81% |
ZYME ZYMEWORKS INC COM | EC | 10,832 | $298,313 | 0.80% |
APGE APOGEE THERAPEUTICS INC COM | EC | 3,580 | $296,746 | 0.79% |
PRTA PROTHENA CORP PLC SHS | EC | 26,642 | $294,661 | 0.79% |
ORIC ORIC PHARMACEUTICALS INC COM | EC | 29,424 | $290,709 | 0.78% |
DNLI DENALI THERAPEUTICS INC COM | EC | 15,351 | $287,371 | 0.77% |
PTGX PROTAGONIST THERAPEUTICS INC COM | EC | 2,894 | $286,419 | 0.77% |
MGTX MEIRAGTX HOLDINGS PLC COM | EC | 30,942 | $285,285 | 0.76% |
IMVT IMMUNOVANT INC COM | EC | 10,446 | $283,557 | 0.76% |
RCKT ROCKET PHARMACEUTICALS INC COM | EC | 81,418 | $283,335 | 0.76% |
QURE UNIQURE NV SHS | EC | 14,147 | $282,233 | 0.76% |
SLNO SOLENO THERAPEUTICS INC COM | EC | 5,306 | $280,263 | 0.75% |
MBX MBX BIOSCIENCES INC COM | EC | 9,242 | $279,293 | 0.75% |
STOK STOKE THERAPEUTICS INC COM | EC | 8,521 | $278,807 | 0.75% |
CYTK CYTOKINETICS INC COM NEW | EC | 4,355 | $278,589 | 0.75% |
CTMX CYTOMX THERAPEUTICS INC COM | EC | 65,872 | $277,980 | 0.74% |
SRRK SCHOLAR ROCK HOLDING CORP COM | EC | 5,888 | $274,440 | 0.74% |
ATAI ATAIBECKLEY INC COM SHS | EC | 64,337 | $267,642 | 0.72% |
NUVL NUVALENT INC COM | EC | 2,633 | $264,037 | 0.71% |
JANX JANUX THERAPEUTICS INC COM | EC | 18,038 | $259,206 | 0.69% |
SEPN SEPTERNA INC COM | EC | 10,849 | $257,772 | 0.69% |
DYN DYNE THERAPEUTICS INC COM | EC | 14,322 | $251,351 | 0.67% |
SION SIONNA THERAPEUTICS INC COM | EC | 6,453 | $249,731 | 0.67% |
KYMR KYMERA THERAPEUTICS INC COM | EC | 3,077 | $249,452 | 0.67% |
ABUS ARBUTUS BIOPHARMA CORP COM | EC | 58,600 | $246,120 | 0.66% |
NRIX NURIX THERAPEUTICS INC COM | EC | 14,473 | $241,699 | 0.65% |
PRME PRIME MEDICINE INC COM | EC | 67,319 | $238,646 | 0.64% |
PROK PROKIDNEY CORP SHS CL A | EC | 124,892 | $237,295 | 0.64% |
ENGN ENGENE THERAPEUTICS INC COM | EC | 32,625 | $237,184 | 0.64% |
IDYA IDEAYA BIOSCIENCES INC COM | EC | 8,112 | $236,059 | 0.63% |
XERS XERIS BIOPHARMA HOLDINGS INC COM | EC | 38,494 | $235,776 | 0.63% |
COGT COGENT BIOSCIENCES INC COM | EC | 6,554 | $234,568 | 0.63% |
VKTX VIKING THERAPEUTICS INC COM | EC | 7,443 | $232,073 | 0.62% |
BHVN BIOHAVEN LTD COM | EC | 23,938 | $229,565 | 0.61% |
EYPT EYEPOINT INC COM NEW | EC | 17,260 | $227,832 | 0.61% |
FDMT 4D MOLECULAR THERAPEUTICS INC COM | EC | 25,461 | $225,839 | 0.60% |
RXRX RECURSION PHARMACEUTICALS INC CL A | EC | 63,742 | $220,547 | 0.59% |
ARVN ARVINAS INC COM | EC | 21,940 | $217,206 | 0.58% |
NAMS NEWAMSTERDAM PHARMA COMPANY NV ORDINARY SHARES | EC | 7,408 | $211,572 | 0.57% |
SVRA SAVARA INC COM | EC | 39,885 | $208,997 | 0.56% |
ASMB ASSEMBLY BIOSCIENCES INC COM NEW | EC | 7,645 | $206,033 | 0.55% |
XNCR XENCOR INC COM | EC | 16,707 | $199,315 | 0.53% |
MLYS MINERALYS THERAPEUTICS INC COM | EC | 7,478 | $199,289 | 0.53% |
IRON DISC MEDICINE INC COM | EC | 3,004 | $198,114 | 0.53% |
VERA VERA THERAPEUTICS INC CL A | EC | 5,541 | $197,315 | 0.53% |
RIGL RIGEL PHARMACEUTICALS INC COM | EC | 6,766 | $195,537 | 0.52% |
MNPR MONOPAR THERAPEUTICS INC COM NEW | EC | 3,699 | $192,903 | 0.52% |
MAZE MAZE THERAPEUTICS INC COM | EC | 7,102 | $188,771 | 0.51% |
RGNX REGENXBIO INC COM | EC | 19,900 | $178,503 | 0.48% |
SANA SANA BIOTECHNOLOGY INC COM | EC | 53,698 | $176,666 | 0.47% |
BCYC BICYCLE THERAPEUTICS PLC SPONSORED ADS | EC | 37,047 | $174,862 | 0.47% |
GPCR STRUCTURE THERAPEUTICS INC SPONSORED ADS | EC | 4,115 | $170,567 | 0.46% |
IVVD INVIVYD INC COM | EC | 118,970 | $166,558 | 0.45% |
LXEO LEXEO THERAPEUTICS INC COM | EC | 28,249 | $160,878 | 0.43% |
VSTM VERASTEM INC COM NEW | EC | 28,720 | $156,811 | 0.42% |
FULC FULCRUM THERAPEUTICS INC COM | EC | 21,230 | $151,370 | 0.41% |
TRAX FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | EC | 6,139 | $142,855 | 0.38% |
KROS KEROS THERAPEUTICS INC COM | EC | 12,830 | $142,670 | 0.38% |
ALT ALTIMMUNE INC COM NEW | EC | 52,374 | $136,172 | 0.36% |
ZBIO ZENAS BIOPHARMA INC COM | EC | 6,799 | $131,357 | 0.35% |
OLMA OLEMA PHARMACEUTICALS INC COM | EC | 8,351 | $120,338 | 0.32% |
WVE WAVE LIFE SCIENCES LTD SHS | EC | 16,665 | $117,655 | 0.32% |
VRDN VIRIDIAN THERAPEUTICS INC COM | EC | 8,542 | $115,146 | 0.31% |
CMPX COMPASS THERAPEUTICS INC COM | EC | 53,489 | $94,676 | 0.25% |
UPB UPSTREAM BIO INC COM | EC | 10,169 | $93,351 | 0.25% |
REPL REPLIMUNE GROUP INC COM | EC | 27,112 | $69,678 | 0.19% |
MREO MEREO BIOPHARMA GROUP PLC SPON ADS | EC | 127,193 | $34,139 | 0.09% |
GOSS GOSSAMER BIO INC COM | EC | 76,668 | $28,198 | 0.08% |